Cargando…
Results of Macitentan in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension ― A Prospective, Multicenter, Open-Label, Single-Arm, Phase 3 Study ―
Background: Macitentan, an endothelin-receptor antagonist, is approved in Japan for the treatment of pulmonary arterial hypertension (PAH). This study evaluated the use of macitentan for chronic thromboembolic pulmonary hypertension (CTEPH) in Japanese patients. Methods and Results: This open-label...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Circulation Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258181/ https://www.ncbi.nlm.nih.gov/pubmed/34250282 http://dx.doi.org/10.1253/circrep.CR-21-0034 |